During the last century, scientists at The University of Texas at Austin played a large role in eliminating the nutritional deficiency diseases that were devastating to children's development with discoveries of vitamins like B5 and B6 and folic acid. Today, a multi-disciplinary group of university researchers from the College of Pharmacy and College of Natural… » Continue Reading
Oncology Researcher Joins University of Texas at Austin Faculty to Study Link Between Obesity and Cancer
Dr. John DiGiovanni, an internationally known cancer researcher who studies the link between obesity and cancer, has joined the pharmacy and nutritional sciences faculty at The University of Texas at Austin. DiGiovanni will hold the Coulter R. Sublett Chair in the College of Pharmacy. He has a joint appointment in the College of Pharmacy's Division… » Continue Reading
Three engineering research projects at The University of Texas at Austin-a protein therapy for liver cancer, an antibody therapy for cancer treatment and an immunity booster to respond to cancer-received $3.3 million from the Cancer Prevention and Research Institute of Texas.
University of Texas at Austin students are learning how to help cancer patients and their families with issues of stress, coping, grief and survivorship through a new course bringing together the fields of social work and oncology, the first academic class of its kind in the nation.
National Institutes of Health Awards $1.5 Million for Male Fertility Research at The University of Texas at Austin
Dr. John Richburg, associate professor of pharmacy at The University of Texas at Austin, has received a five-year $1.5 million National Institutes of Health (NIH) grant to study the adverse effects of environmental toxicants on male fertility and disease.
The University of Texas at Austin has licensed technology for a probe that would quickly scan skin to detect skin cancer to DermDx Inc., a company based in Fresno, Calif.
University of Texas at Austin Pharmacy Faculty Member’s Research on Lymphoma Published in Science Magazine
Using cancer cells that were originally isolated from an anaplastic large cell lymphoma patient, two researchers, including a faculty member of The University of Texas at Austin's College of Pharmacy, have identified a novel regulatory mechanism in inflammatory signaling of immune cells that may prove beneficial in treating cancer.
Premier $55 Million Biomedical Engineering Building Opens for Teaching and Research at the University
The University of Texas at Austin will dedicate on Thursday, Aug. 28 a new $55 million Biomedical Engineering building, which is being touted as a world-class facility for interdisciplinary research and collaboration in biomedical engineering, pharmacy and natural sciences.
A biomedical engineering assistant professor at The University of Texas at Austin has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research.
Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.